{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:06:23Z","timestamp":1793408783943,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with rare diseases often encounter significant challenges, including poor coordination of healthcare services. The UK Rare Disease Framework emphasizes key priorities such as faster diagnoses, greater awareness among healthcare professionals, improved care coordination, and better access to specialist care. This National Health Service (NHS) project, based in the North East and Yorkshire Genomic Medicine Service (GMS), aimed to improve care coordination for patients with rare genetic diseases in primary care. The project focused on developing a generic clinical pathway to improve care coordination and transitions of care that could be applied to a range of rare diseases. Additionally, it sought to strengthen the integration between genomic services and primary care, fostering a more cohesive approach to patient management. The project mapped clinical care pathways for two exemplar rare genetic diseases, Achondroplasia and Neurofibromatosis type 1 (NF1), this paper describes the NF1 pathway and broader learning from this project. The pathways focussed on identifying common clinical touchpoints with primary care and transitions between primary and specialty care. Key findings included the identification of gaps in care coordination, particularly during the transition from paediatric to adult services, and the development of a set of principles and a template for mapping other rare diseases. Feedback from a wide range of stakeholders, including clinicians across specialties and patient representatives, informed the refinement of the pathways. This project illustrates a systematic approach to enhancing care coordination for patients with rare genetic diseases through the mapping of clinical pathways and the development of primary care resources. The principles and template created can be adapted for other rare diseases, enabling the development of concise, disease-specific pathways. By prioritizing care coordination and transitions, and engaging a wide range of stakeholders in the process, this approach offers significant potential to improve the management of rare disease patients, especially during the critical transition from paediatric to adult care.<\/jats:p>","DOI":"10.1007\/s12687-025-00811-5","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:52:22Z","timestamp":1751518342000},"page":"747-757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing care coordination for neurofibromatosis type 1 in primary care: insights and applications for rare diseases"],"prefix":"10.1007","volume":"16","author":[{"given":"William","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaynee","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"811_CR1","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(24)00134-7","volume":"12","author":"G Baynam","year":"2024","unstructured":"Baynam G, Hartman AL, Letinturier MCV, Bolz-Johnson M, Carrion P, Grady AC, Dong X, Dooms M, Dreyer L, Graessner H, Granados A, Groza T, Houwink E, Jamuar SS, Vasquez-Loarte T, Tumiene B, Wiafe SA, Bjornson-Pennell H, Groft S (2024) Global health for rare diseases through primary care. Lancet Glob Health 12:e1192\u2013e1199. https:\/\/doi.org\/10.1016\/S2214-109X(24)00134-7","journal-title":"Lancet Glob Health"},{"key":"811_CR2","doi-asserted-by":"publisher","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L (2010). AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ Can Med Assoc J 182:E839\u2013E842. https:\/\/doi.org\/10.1503\/cmaj.090449","DOI":"10.1503\/cmaj.090449"},{"key":"811_CR3","unstructured":"CamRare (2022) Transitions - Cambridge Rare Disease Network [WWW Document]. URL https:\/\/www.camraredisease.org\/collaboration-transitions\/ (accessed 4.28.23)"},{"key":"811_CR4","doi-asserted-by":"publisher","unstructured":"Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, Salvador H, Azizi AA, Mautner V, R\u00f6hl C, Peltonen S, Stivaros S, Legius E, Oostenbrink R, Brunet J, Calenbergh FV, Cassiman C, Czech T, Le\u00f3n MJG, de Giele H, Henley S, Lazaro C, Lipkovskaya V, Maher ER, Martin V, Mathijssen I, Opocher E, Pires AE, Pletschko T, Poupaki E, Ridola V, Rietman A, Rosenbaum T, Santhouse A, Sehested A, Simmons I, Taal W, Wagner A (2023) ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. eClinicalMedicine 56. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101818","DOI":"10.1016\/j.eclinm.2022.101818"},{"key":"811_CR5","unstructured":"Department of Health and Social Care (2021) The UK Strategy for Rare Diseases. [WWW Document]. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/260562\/UK_Strategy_for_Rare_Diseases.pdf. (Accessed 7.28.23)."},{"key":"811_CR7","unstructured":"Dept of Health and Social Care (2023) England Rare Diseases Action Plan 2023: main report [WWW Document]. GOV.UK. URL https:\/\/www.gov.uk\/government\/publications\/england-rare-diseases-action-plan-2023\/england-rare-diseases-action-plan-2023-main-report (accessed 4.28.23)."},{"key":"811_CR6","unstructured":"Dept of Health and Social Care (2024) England Rare Diseases Action Plan 2024 [WWW Document]. GOV.UK. URL https:\/\/www.gov.uk\/government\/publications\/england-rare-diseases-action-plan-2024\/england-rare-diseases-action-plan-2024-main-report (accessed 5.10.24)."},{"key":"811_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-017-0618-0","volume":"12","author":"S Dharssi","year":"2017","unstructured":"Dharssi S, Wong-Rieger D, Harold M, Terry S (2017) Review of 11 National policies for rare diseases in the context of key patient needs. Orphanet J Rare Dis 12:63. https:\/\/doi.org\/10.1186\/s13023-017-0618-0","journal-title":"Orphanet J Rare Dis"},{"key":"811_CR19","unstructured":"England NHS (2019) The NHS Long Term Plan [WWW Document]. URL https:\/\/www.longtermplan.nhs.uk\/online-version\/overview-and-summary\/ (accessed 11.3.23)"},{"key":"811_CR18","unstructured":"England NHS (2024) Learning Disability Annual health checks [WWW Document]. URL https:\/\/www.england.nhs.uk\/learning-disabilities\/improving-health\/annual-health-checks\/ (accessed 5.1.23)"},{"key":"811_CR9","doi-asserted-by":"crossref","unstructured":"Evans WRH, Rafi I (2016) Rare diseases in general practice: recognising the zebras among the horses. Br J Gen Pract 66:550 LP\u2013 551","DOI":"10.3399\/bjgp16X687625"},{"key":"811_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12687-020-00457-5","volume":"11","author":"WRH Evans","year":"2020","unstructured":"Evans WRH, Tranter J, Rafi I, Hayward J, Qureshi N (2020) How genomic information is accessed in clinical practice: an electronic survey of UK general practitioners. J Community Genet 11:377\u2013386. https:\/\/doi.org\/10.1007\/s12687-020-00457-5","journal-title":"J Community Genet"},{"key":"811_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81\u201388. https:\/\/doi.org\/10.1136\/jmg.2006.045906","journal-title":"J Med Genet"},{"key":"811_CR12","unstructured":"Friedman JM (1993) Neurofibromatosis 1. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds) GeneReviews\u00ae. University of Washington, Seattle. Seattle (WA)."},{"key":"811_CR13","unstructured":"JARDIN WP6 Task 6.2 (2025) JARDIN Care Pathways Toolkit, Care pathways toolkit for healthcare professionals and patient representatives (Version 4.4)"},{"key":"811_CR14","unstructured":"Manchester Centre for Genomic Medicine (2019) Neurofibromatosis Type 1 Review Guidelines [WWW Document]. URL https:\/\/www.mangen.co.uk\/healthcare-professionals\/clinical-genomic-services\/nf1\/ (accessed 6.28.23)"},{"key":"811_CR15","doi-asserted-by":"publisher","first-page":"e20190660","DOI":"10.1542\/peds.2019-0660","volume":"143","author":"DT Miller","year":"2019","unstructured":"Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR, Council on Genetics, American College of Medical Genetics and Genomics, Chen E, Trotter TL, Berry SA, Burke LW, Geleske TA, Hamid R, Hopkin RJ, Introne WJ, Lyons MJ, Scheuerle AE, Stoler JM (2019) Health supervision for children with neurofibromatosis type 1. Pediatrics 143:e20190660. https:\/\/doi.org\/10.1542\/peds.2019-0660","journal-title":"Pediatrics"},{"key":"811_CR16","unstructured":"Nerve Tumours UK (2023) Support for Medics (NF1) [WWW Document]. Nerve Tumours UK. URL https:\/\/nervetumours.org.uk\/what-are-nerve-tumours\/what-is-nf1\/support-for-medics-nf1 (accessed 5.1.23)"},{"key":"811_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0508-0","author":"S Nguengang Wakap","year":"2019","unstructured":"Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y, Rath A (2019) Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. https:\/\/doi.org\/10.1038\/s41431-019-0508-0","journal-title":"Eur J Hum Genet"},{"key":"811_CR20","unstructured":"NHS Health Education England (2024) GeNotes: genomic notes for clinicians [WWW Document]. Genomics Educ. Programme. URL https:\/\/www.genomicseducation.hee.nhs.uk\/about-us\/genotes-genomic-notes-for-clinicians\/ (accessed 5.1.23)."},{"key":"811_CR21","unstructured":"NICE (2016) Transition from children\u2019s to adults\u2019 services| Quality standards| NICE [WWW Document]. URL https:\/\/www.nice.org.uk\/guidance\/qs140 (accessed 5.10.24)"},{"key":"811_CR22","unstructured":"NICE (2015) Health Technologies Adoption Programme Mapping care pathways [WWW Document]. URL https:\/\/www.nice.org.uk\/media\/default\/About\/what-we-do\/Into-practice\/HTAP\/HTAPMappingCarePathwaysResource.pdf (accessed 2.2.25)"},{"key":"811_CR23","unstructured":"Orphadata (2023) Orphadata\u2013 Orphanet datasets [WWW Document]. URL https:\/\/www.orphadata.com\/ (accessed 5.2.23)"},{"key":"811_CR24","unstructured":"Rare disease UK (2016) The Rare Reality - An insight into the patient and family experience of rare disease"},{"key":"811_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/gim.2018.28","volume":"20","author":"DR Stewart","year":"2018","unstructured":"Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K (2018) Care of adults with neurofibromatosis type 1: a clinical practice resource of the American college of medical genetics and genomics (ACMG). Genet Med 20:671\u2013682. https:\/\/doi.org\/10.1038\/gim.2018.28","journal-title":"Genet Med"},{"key":"811_CR26","unstructured":"UN (2021) Addressing the challenges of persons living with a rare disease and their families:: resolution \/. adopted by the General Assembly"},{"key":"811_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-019-1075-8","volume":"14","author":"L Vandeborne","year":"2019","unstructured":"Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I (2019) Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis 14:99. https:\/\/doi.org\/10.1186\/s13023-019-1075-8","journal-title":"Orphanet J Rare Dis"},{"key":"811_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5334\/ijic.5464","volume":"20","author":"H Walton","year":"2020","unstructured":"Walton H, Hudson E, Simpson A, Ramsay AIG, Kai J, Morris S, Sutcliffe AG, Fulop NJ (2020) Defining coordinated care for people with rare conditions: A scoping review. Int J Integr Care 20:14. https:\/\/doi.org\/10.5334\/ijic.5464","journal-title":"Int J Integr Care"},{"key":"811_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13023-022-02190-3","volume":"17","author":"H Walton","year":"2022","unstructured":"Walton H, Simpson A, Ramsay AIG, Hunter A, Jones J, Ng PL, Leeson-Beevers K, Bloom L, Kai J, Kokocinska M, Sutcliffe AG, Morris S, Fulop NJ (2022) Development of models of care coordination for rare conditions: a qualitative study. Orphanet J Rare Dis 17:49. https:\/\/doi.org\/10.1186\/s13023-022-02190-3","journal-title":"Orphanet J Rare Dis"},{"key":"811_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-022-02309-6","volume":"17","author":"AJ Ward","year":"2022","unstructured":"Ward AJ, Murphy D, Marron R, McGrath V, Bolz-Johnson M, Cullen W, Daly A, Hardiman O, Lawlor A, Lynch SA, MacLachlan M, McBrien J, Bhriain N, O\u2019Byrne S, O\u2019Connell JJ, Turner SM, Treacy J, E.P (2022) Designing rare disease care pathways in the Republic of ireland: a co-operative model. Orphanet J Rare Dis 17:162. https:\/\/doi.org\/10.1186\/s13023-022-02309-6","journal-title":"Orphanet J Rare Dis"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-025-00811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-025-00811-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-025-00811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:12:57Z","timestamp":1761707577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-025-00811-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1007\/s12687-025-00811-5","relation":{},"ISSN":["1868-6001"],"issn-type":[{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}